These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26704983)

  • 21. Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells.
    Cheng TL; Chang WT
    Methods Mol Biol; 2007; 408():223-41. PubMed ID: 18314586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of gene GSTP1 silencing via shRNA transfection on androgen independent prostate cancer cell line Du145].
    Jin P; Xie J; Zhu X; Zhou C; Ding X; Yang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):807-16. PubMed ID: 22954916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CKD712, a synthetic isoquinoline alkaloid, enhances the anti-cancer effects of paclitaxel in MDA-MB-231 cells through regulation of PTEN.
    Kim YM; Tsoyi K; Jang HJ; Park EJ; Park SW; Kim HJ; Hwa JS; Chang KC
    Life Sci; 2014 Sep; 112(1-2):49-58. PubMed ID: 25058922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
    Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
    J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retroviral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcription.
    Yamagishi M; Ishida T; Miyake A; Cooper DA; Kelleher AD; Suzuki K; Watanabe T
    Microbes Infect; 2009 Apr; 11(4):500-8. PubMed ID: 19233310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA interference-mediated silencing of Foxo3 in antigen-presenting cells as a strategy for the enhancement of DNA vaccine potency.
    Wang ST; Chang CC; Yen MC; Tu CF; Chu CL; Peng YT; Chen DY; Lan JL; Lin CC
    Gene Ther; 2011 Apr; 18(4):372-83. PubMed ID: 21107437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NZ28-induced inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells.
    Schilling D; Kühnel A; Tetzlaff F; Konrad S; Multhoff G
    Cancer Immunol Immunother; 2015 May; 64(5):599-608. PubMed ID: 25854583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterisation and application of a bovine U6 promoter for expression of short hairpin RNAs.
    Lambeth LS; Moore RJ; Muralitharan M; Dalrymple BP; McWilliam S; Doran TJ
    BMC Biotechnol; 2005 May; 5():13. PubMed ID: 15885150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization and comparison of chicken U6 promoters for the expression of short hairpin RNAs.
    Wise TG; Schafer DJ; Lambeth LS; Tyack SG; Bruce MP; Moore RJ; Doran TJ
    Anim Biotechnol; 2007; 18(3):153-62. PubMed ID: 17612838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-administration of liposomal l-OHP and PEGylated TS shRNA-lipoplex: A novel approach to enhance anti-tumor efficacy and reduce the immunogenic response to RNAi molecules.
    Alaaeldin E; Abu Lila AS; Ando H; Fukushima M; Huang CL; Wada H; Sarhan HA; Khaled KA; Ishida T
    J Control Release; 2017 Jun; 255():210-217. PubMed ID: 28461099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Innate immune response to double-stranded RNA in biliary epithelial cells is associated with the pathogenesis of biliary atresia.
    Harada K; Sato Y; Itatsu K; Isse K; Ikeda H; Yasoshima M; Zen Y; Matsui A; Nakanuma Y
    Hepatology; 2007 Oct; 46(4):1146-54. PubMed ID: 17661372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
    Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I:C), on human breast cancer.
    Inao T; Harashima N; Monma H; Okano S; Itakura M; Tanaka T; Tajima Y; Harada M
    Breast Cancer Res Treat; 2012 Jul; 134(1):89-100. PubMed ID: 22203435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection and optimization of asymmetric siRNA targeting the human c-MET gene.
    Jo SG; Hong SW; Yoo JW; Lee CH; Kim S; Kim S; Lee DK
    Mol Cells; 2011 Dec; 32(6):543-8. PubMed ID: 22058018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of interferon-stimulated gene induction by RNAi vectors.
    Pebernard S; Iggo RD
    Differentiation; 2004 Mar; 72(2-3):103-11. PubMed ID: 15066190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma.
    Nojiri K; Sugimoto K; Shiraki K; Tameda M; Inagaki Y; Kusagawa S; Ogura S; Tanaka J; Yoneda M; Yamamoto N; Okano H; Takei Y; Ito M; Kasai C; Inoue H; Takase K
    Oncol Rep; 2013 May; 29(5):1737-43. PubMed ID: 23467704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
    Tse AK; Wan CK; Shen XL; Yang M; Fong WF
    Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting BCR-ABL fusion gene in Chronic Myeloid Leukemia cells.
    Arthanari Y; Pluen A; Rajendran R; Aojula H; Demonacos C
    J Control Release; 2010 Aug; 145(3):272-80. PubMed ID: 20403398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, gene-silencing activity and nuclease resistance of 3'-3'-linked double short hairpin RNA.
    Masuda H; Watanabe N; Naruoka H; Nagata S; Takagaki K; Wada T; Yano J
    Bioorg Med Chem; 2010 Dec; 18(23):8277-83. PubMed ID: 21051237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of delivery systems on siRNA immune activation and RNA interference.
    Forsbach A; Müller C; Montino C; Kritzler A; Curdt R; Benahmed A; Jurk M; Vollmer J
    Immunol Lett; 2012 Jan; 141(2):169-80. PubMed ID: 22001011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.